NeurologyLive ™ Launches Peer Exchange ‘Chronic Migraine: New Paradigms in Management’

The expert panel focuses on the specific information and educational
needs of health care professionals

involved in the diagnosis
and treatment of chronic migraine

a digital and print media enterprise platform dedicated to providing
health care professionals treating neurological diseases direct access
to expert practice-changing news and insights in neurology, presents its
most recent Peer Exchange panel discussion titled “Chronic
Migraine: New Paradigms in Management.”
The video series
welcomes several experts in headache medicine who provide peer-to-peer
dialogue, authoritative insights, opinions and perspectives on important
issues facing today’s health care professionals treating chronic

“We are so thrilled to launch this cutting edge chronic migraine video
series to healthcare professionals treating neurological diseases,” said
Michael J. Hennessy Jr., president of MJH Associates, parent company of NeurologyLive.
“This exchange was designed to bring together experts in the field of
headache medicine to discuss the use of new and exciting therapeutic
options, review the latest clinical trials and provide neurology
professionals with a perspective on how some of the recent data applies
to their everyday clinical practice.”

This NeurologyLiveTM Peer Exchange
discussion features Stephen D. Silberstein, M.D., professor of
neurology, director, Jefferson Headache Center at Thomas Jefferson
University, as the moderator; and Peter Goadsby, M.D., M.B.B.S.,
Ph.D., DS.c
, professor of neurology, University of California San
Francisco and King’s College, London, director of the NIHR/Wellcome
Trust Clinical Research Facility, King’s College Hospital; and Stewart
Tepper, M.D.
, director, Dartmouth Headache Clinic,
Dartmouth-Hitchcock Medical Center, professor of neurology, Geisel
School of Medicine at Dartmouth College; and Jessica Ailani, M.D.,
director, MedStar Georgetown University Hospital Headache Center,
associate professor of neurology, Georgetown University; and David
Dodick, M.D., M.S.
, professor of neurology, Mayo Clinic College of
Medicine in Scottsdale, Arizona, director, Concussion and Headache
Program, Mayo Clinic, who provided an overview of the latest clinical
trials and practical perspective on how the recent data applies to
everyday clinical practice.

Chronic migraines are a neurological disease associated with extensive
disability and poor quality of life. Successful treatment often requires
a multifaceted approach. In the first segment of the series, this Peer
provides an in-depth look at what is known in the biology
of migraine.
Panelists explored the part played by genetics,
migraine-associated conditions, as well as the differentiating facets of
migraine with and without aura, the role of the trigeminal nerve plays
and a look into vascular theory.

For more information and to view the video series, click here.

About NeurologyLive

A digital and print media platform for healthcare professionals treating
neurological diseases, NeurologyLive delivers direct
access to practice-changing news and expert insight directly from top
medical conferences and researchers to improve the lives of patients
with neurological diseases, such as dementia and Alzheimer’s disease,
epilepsy, headache and migraine, movement disorders, multiple sclerosis,
neuromuscular diseases, sleep medicine and stroke. NeurologyLive
offers an in-depth look at hundreds of new treatments in
development with ever-expanding mechanisms of action, all during an
unprecedented time of growing demand for neurology expertise. The NeurologyLive
platform also connects visitors with the most up-to-date clinical trial
results, Food and Drug Administration approvals, practice-changing
research and expert insight. NeurologyLive is
part of the Cranbury, New Jersey-based MJH Associates Inc. health care
enterprise, which includes OncLive® and CURE®
magazine. For more information, visit


NeurologyLive Media Contacts:
Ventura, 609-716-7777, ext. 121

John Patricolo, 609-325-4630